COMMUNIQUÉS West-GlobeNewswire

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
02/09/2026
MONTREAL and CHARLOTTE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
02/09/2026
NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10 th Annual Best Ideas Growth “ [...]
Solid Biosciences to Participate at Upcoming Investor Conferences
02/09/2026
CHARLESTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
ProQR to Participate in Upcoming Investor Conferences in September 2026
02/09/2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies [...]
Seismic Therapeutic to Participate in Upcoming Investor Conferences
02/09/2026
WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc. today announced that company management will participate in the following investor conferences: Wells Fargo 2026 Healthcare Conference Date [...]
Alpha Tau to Participate in September Investor Conferences
02/09/2026
JERUSALEM, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
SpyGlass Pharma to Participate in Upcoming Investor Conferences
02/09/2026
IRVINE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma” or “Company”), a late-stage biopharmaceutical company, today announced that members of the executive management [...]
ALX Oncology to Present at Upcoming Investor Conferences in September
02/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat [...]
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
02/09/2026
NAARDEN, The Netherlands and MIAMI, Sept. 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]
Annexon to Participate in Upcoming September Investor Conferences
02/09/2026
BRISBANE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Geron to Present at Upcoming Investor Conferences
02/09/2026
FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
02/09/2026
ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company [...]
Amlogenyx to Present at the Wells Fargo 21ˢᵗ Annual Healthcare Conference
02/09/2026
NOVATO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amlogenyx, Inc., a biotechnology company focused on developing gene therapies for Alzheimer’s disease and other neurodegenerative diseases, today announced members of [...]
vTv Therapeutics to Participate in September Investor Conferences
02/09/2026
HIGH POINT, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), [...]
Disc Medicine to Participate in Upcoming Investor Conferences
02/09/2026
WATERTOWN, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
BioAge Labs to Present at Upcoming Investor Conferences
02/09/2026
EMERYVILLE, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic [...]
CG Oncology to Present at Upcoming Investor Conferences in September
02/09/2026
DALLAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the [...]
Novonesis to build next generation enzyme production facility in India
02/09/2026
Novonesis will invest €600 million to expand its site in  Patalganga  and build a state-of-the-art facility. This marks another step in the company's long-term growth strategy and continued investment in its global [...]
Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
02/09/2026
SANDWICH, United Kingdom, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class clinical-stage treatment for osteoarthritis (OA), today [...]

Pages